Compare IDT & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDT | PLSE |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.5B |
| IPO Year | N/A | 2015 |
| Metric | IDT | PLSE |
|---|---|---|
| Price | $48.71 | $22.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | 123.1K | ★ 306.8K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.99 | $912.86 |
| Revenue Next Year | N/A | $259.66 |
| P/E Ratio | $15.10 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $45.35 | $12.56 |
| 52 Week High | $71.12 | $26.30 |
| Indicator | IDT | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 42.28 | 62.33 |
| Support Level | $46.91 | $13.75 |
| Resistance Level | $50.65 | $26.30 |
| Average True Range (ATR) | 1.53 | 1.23 |
| MACD | -0.32 | 0.12 |
| Stochastic Oscillator | 24.20 | 87.22 |
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.